Clicky

Panbela Therapeutics, Inc.(PBLA)

Description: Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing disruptive therapeutics for patients with urgent unmet medical needs. The company’s initial product candidate, SBP-101, is for the treatment of patients with metastatic pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer. Panbela Therapeutics, Inc. is dedicated to treating patients with pancreatic cancer and exploring SBP-101’s potential for efficacy in combination with other agents and in treating other types of cancer.


Keywords: Medicine Cancer Biopharmaceutical Clinical Medicine Pancreatic Cancer Carcinoma Gastrointestinal Cancer Mm 151

Home Page: www.panbela.com

PBLA Technical Analysis

712 Vista Boulevard
Waconia, MN 55387
United States
Phone: 952 479 1196


Officers

Name Title
Dr. Jennifer K. Simpson C.R.N.P., CRNP, M.S.N., Ph.D. CEO, Pres & Director
Ms. Susan Horvath VP of Fin., CFO, Sec. & Treasurer
Ms. Tammy Groene VP of Operations
Dr. Elizabeth Bruckheimer Ph.D. VP & Chief Scientific Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 3.2198
Price-to-Sales TTM: 0
IPO Date: 2017-01-03
Fiscal Year End: December
Full Time Employees: 4
Back to stocks